News
News
- Novan Secures Up to $35 Million in Non-Dilutive Funding
04/29/2019 / 22:15 - GlobeNewswire - Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
04/23/2019 / 22:02 - GlobeNewswire - Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
04/23/2019 / 22:01 - GlobeNewswire - Novartis continues transformation into a leading medicines company with completion of the Alcon spin-off
04/09/2019 / 07:00 - GlobeNewswire - Novartis plans for Alcon spin-off on April 9, 2019
03/22/2019 / 07:00 - GlobeNewswire - Novan and Sato Advance Japan Market and Dermatology Partnership
03/19/2019 / 15:00 - GlobeNewswire - Novan Completes End-of-Phase 2 Meeting and Provides Additional Business Updates
03/11/2019 / 10:00 - GlobeNewswire - Novan Provides Business Update
01/30/2019 / 23:15 - GlobeNewswire - Novan Announces Management Changes and Provides Business Update
01/02/2019 / 13:15 - GlobeNewswire - Novan to Present Data from SB414 Phase 1b Atopic Dermatitis Clinical Trial at 3rd Inflammatory Skin Disease Summit
12/11/2018 / 15:00 - GlobeNewswire
Real-time